Efficacy of the Motivational Interviewing–Walk Intervention for Chemotherapy-Induced Peripheral Neuropathy and Quality of Life During Oxaliplatin Treatment: A Pilot Randomized Controlled Trial
Conclusions
This study failed to detect beneficial effects of the MI-Walk intervention; however, the findings suggest that aerobic walking may blunt but not completely prevent OIPN. Further research is necessary.
Implications for Practice
Although the effectiveness of brisk walking in reducing OIPN is unclear, this study supports prior evidence that moderate to vigorous PA is beneficial and safe during chemotherapy treatment.
Source: Cancer Nursing - Category: Nursing Tags: ARTICLES: ONLINE ONLY Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Education | Eloxatin | Gastroenterology | Neurology | Nurses | Nursing | Peripheral Neuropathy | Study | Universities & Medical Training